Stock ASTEC ASTEC LIFESCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Astec LifeSciences Limited

Equities

ASTEC

INE563J01010

Agricultural Chemicals

Market Closed - NSE India S.E.
Other stock markets
 07:43:46 2024-04-26 am EDT 		5-day change 1st Jan Change
1,220 INR -1.94% Intraday chart for Astec LifeSciences Limited -1.83% +11.35%
Jan. 25 Astec LifeSciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
2023 Astec LifeSciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 10,520 7,598 19,653 34,391 27,154 23,915 - -
Enterprise Value (EV) 1 10,520 7,598 21,507 37,163 27,154 23,915 23,915 23,915
P/E ratio 29.5 x 16 x 30.2 x 38.3 x 106 x -56.2 x 41.3 x 25.7 x
Yield - - 0.15% 0.09% 0.11% - 0.08% 0.08%
Capitalization / Revenue 2.44 x 1.45 x 3.54 x 5.08 x 4.32 x 5.56 x 3.54 x 2.74 x
EV / Revenue 2.44 x 1.45 x 3.54 x 5.08 x 4.32 x 5.56 x 3.54 x 2.74 x
EV / EBITDA 12 x - 17.6 x 22.3 x 35.6 x -629 x 17.6 x 12 x
EV / FCF - - -17,754,754 x -42,788,249 x - - - -
FCF Yield - - -0% -0% - - - -
Price to Book 5.19 x - 6.36 x 8.68 x - 6.35 x 5.52 x 4.55 x
Nbr of stocks (in thousands) 19,553 19,568 19,578 19,593 19,606 19,609 - -
Reference price 2 538.0 388.3 1,004 1,755 1,385 1,220 1,220 1,220
Announcement Date 4/30/19 5/5/20 4/30/21 5/2/22 5/2/23 - - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 4,309 5,226 5,549 6,766 6,282 4,300 6,756 8,716
EBITDA 1 876.3 - 1,116 1,541 762.5 -38 1,359 1,985
EBIT 1 - - 859 1,197 426 -417 888 1,420
Operating Margin - - 15.48% 17.69% 6.78% -9.7% 13.14% 16.29%
Earnings before Tax (EBT) 1 559 - 890.7 1,211 349.5 -568 733 1,244
Net income 1 357.7 - 650.5 898.6 255.6 -425 579 931
Net margin 8.3% - 11.72% 13.28% 4.07% -9.88% 8.57% 10.68%
EPS 2 18.26 24.27 33.21 45.85 13.04 -21.70 29.50 47.50
Free Cash Flow - - -1,107 -803.7 - - - -
FCF margin - - -19.95% -11.88% - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - - 1.500 1.500 1.500 - 1.000 1.000
Announcement Date 4/30/19 5/5/20 4/30/21 5/2/22 5/2/23 - - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2024 S2
Net sales 1 - 1,719 1,287 1,026 1,734 2,720 1,843 1,997 1,172 1,270 1,428 1,230 936 1,546 -
EBITDA 1 - 381.9 246.7 210.8 428.6 654.6 254.5 332.8 121.2 54 31.32 18 0.5 98.5 -80
EBIT 1 - - - - - - - - - - -62.53 - -219 6 -
Operating Margin - - - - - - - - - - -4.38% - -23.4% 0.39% -
Earnings before Tax (EBT) - - - - - - - - - - - - - - -
Net income 1 70.58 - - - - 430.5 - - - - -81.95 - - -34 -
Net margin - - - - - 15.83% - - - - -5.74% - - -2.2% -
EPS 2 - - - - 12.62 - - - - - -4.180 - - -1.800 -
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 1/25/21 4/30/21 7/28/21 10/27/21 1/25/22 5/2/22 7/25/22 10/28/22 1/30/23 5/2/23 7/28/23 - - - -
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - 1,855 2,772 - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - 1.662 x 1.799 x - - - -
Free Cash Flow - - -1,107 -804 - - - -
ROE (net income / shareholders' equity) 19.2% - 23.4% 25.5% - -11% 14% -
ROA (Net income/ Total Assets) - - 10.4% 11.4% 2.73% - - -
Assets 1 - - 6,247 7,872 9,381 - - -
Book Value Per Share 2 104.0 - 158.0 202.0 - 192.0 221.0 268.0
Cash Flow per Share - - -4.170 - - - - -
Capex 1 - - 1,025 1,040 1,173 1,358 1,200 1,200
Capex / Sales - - 18.48% 15.37% 18.67% 31.58% 17.76% 13.77%
Announcement Date 4/30/19 5/5/20 4/30/21 5/2/22 5/2/23 - - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Astec LifeSciences Limited

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1,220 INR
Average target price
1,108 INR
Spread / Average Target
-9.19%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Agricultural Chemicals

1st Jan change Capi.
ASTEC LIFESCIENCES LIMITED Stock Astec LifeSciences Limited
+11.35% 287M
CORTEVA, INC. Stock Corteva, Inc.
+14.61% 38.38B
PHOSAGRO Stock PhosAgro
-.--% 11.15B
FMC CORPORATION Stock FMC Corporation
-7.28% 7.3B
PI INDUSTRIES LIMITED Stock PI Industries Limited
+7.47% 6.87B
ICL GROUP LTD Stock ICL Group Ltd
-3.91% 5.91B
THE FERTILISERS AND CHEMICALS TRAVANCORE LIMITED Stock The Fertilisers and Chemicals Travancore Limited
-10.44% 5.6B
OCI N.V. Stock OCI N.V.
-6.14% 5.54B
YUNNAN YUNTIANHUA CO., LTD. Stock Yunnan Yuntianhua Co., Ltd.
+31.35% 5.19B
UPL LIMITED Stock UPL Limited
-13.45% 4.58B
Other Agricultural Chemicals
  1. Stock Market
  2. Equities
  3. ASTEC Stock
  4. Financials Astec LifeSciences Limited